Investing Profile

Carol Gallagher

OperatorAdvisor
Venture Advisor at New Enterprise Associates (NEA)
nea.com/team/carol-gallagherCalifornia
Photo of Carol Gallagher, Advisor at New Enterprise Associates (NEA)
Your Intro Paths to Carol Gallagher

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Carol Gallagher on

cb
Current Investing Position
New Enterprise Associates (NEA) Advisor
Investments On Record
11
Current Fund Size
$6.2B

Carol Gallagher is on these Sector & Stage Rankings

Carol Gallagher's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
Recludix Pharma
Series ANov 2021$60M
$60M
Co-investors: Matthew McAviney (New Enterprise Associates (NEA))
ChromaCode
Series CDec 2019$28M
$50M
Co-investors: Jenny Yip (Adjuvant Capital), Charles Petty (Global Health Investment Corporation), James Blair (Domain Associates), Justin Klein (Vensana Capital)
Millendo Therapeutics
Series UnknownAug 2018$30M
Series BJan 2016$62M
$110M
Co-investors: Bill Harrington (Osage University Partners (OUP)), James N. Topper (Xelas Consulting LLC)
Metacrine
Series CJun 2018$65M
Series BDec 2017$22M
$140M
Co-investors: Anup Arora (K2 HealthVentures)
Pionyr Immunotherapeutics
Series BDec 2017$62M
$79M
Co-investors: Jack Kenney (SV Health Investors), Leon Chen (The Column Group), Michael Powell (Omega Funds), Arjun Goyal (Vida Ventures)
Good2Go, Inc.
Seed RoundSep 2017$7M
$7M
Co-investors: Ruby Lee
Good2Go, Inc
SeedSep 2017$7M
$7M
Co-investors: Bob Pavey (Morgenthaler Ventures), Shailesh Rao (TPG Biotech), Corey Goodman (venBio), Nancy Schoendorf (Mohr Davidow Ventures)
Cleave Therapeutics
Series BAug 2016$37M
Series AApr 2013$10M
$100M
Co-investors: Peter Thompson (OrbiMed), Kush Parmar (5am Ventures), Andrew Schwab (5am Ventures), Marc Singer (Osage University Partners), Robert Garland (CrowdQuest), Alfred Scheidegger (Nextech Invest), Larry Lasky (The Column Group)